Sort
48,018 grants matching “immunotherapy”
Novel Approaches to Targeting Cancers Associated with VHL Mutations
$630,437Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS
$630,404Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Exercise as an Immune Adjuvant for Gamma Delta T-cell Therapies in Hematologic Malignancies
$630,238Richard J Simpson · University Of Arizona · R01 · FY2025 · CA
Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay
$630,231Yun Wu · State University Of New York At Buffalo · R01 · FY2023 · CA
Heterlogous Prime and Boost Vaccine Strategies
$630,187Jonathan Smith · Duke University · P01 · FY2007 · CA
Developing an Oncology Workforce for the 21st Century
$630,175Olufunmilayo I Olopade · University Of Chicago · K12 · FY2021 · CA
Shark Radiotherapy for the Treatment of Triple-Negative Breast Cancer
$630,171Aaron Matthew Lebeau · University Of Wisconsin-Madison · R01 · FY2025 · CA
Co-Clinical Research Resource for Imaging Tumor Associated Macrophages
$630,142Heike Elizabeth Daldrup-Link · Stanford University · U24 · FY2022 · CA
Comparative Modeling for the Prevention and Control of Uterine Cancer
$630,059Jason Wright · Columbia University Health Sciences · U01 · FY2025 · CA
Advancing RAS pathway targeted therapy in NF1-MPNST: effects of SHP2 and CDK4/6 inhibitors on the tumor and the tumor immune microenvironment
$630,037Christine Anne Pratilas · Johns Hopkins University · R01 · FY2025 · CA
Epigenetic control of Foxp3 expression in induced T regulatory cells
$630,000Anjana Rao · La Jolla Institute For Immunology · R01 · FY2018 · AI
Multiplexed drug testing of micro-dissected tumors using a microfluidic platform with integrated electrochemical aptasensors
$629,966Albert Folch · University Of Washington · R01 · FY2024 · CA
Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer
$629,761Rebecca L Aft · Washington University · R01 · FY2021 · CA
Adoptive Transfer of MART-1 TCR Engineered Cells after a Myelodepleting Regimen
$629,729Antoni Ribas · California Institute Of Technology · P01 · FY2013 · CA
Predict radiation-induced shifts in patient-specific tumor immune ecosystem composition to harness immunological consequences of radiotherapy
$629,676Heiko Enderling · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2021 · CA
Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer
$629,612Kwok Kin Wong · New York University School Of Medicine · U01 · FY2020 · CA
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
$629,550Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2020 · CA
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
$629,550Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2018 · CA
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
$629,550Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2017 · CA
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
$629,550Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2019 · CA
Regulatory T Cell Function in Ovarian Cancer
$629,546Kirsten B Moysich · Roswell Park Cancer Institute Corp · R01 · FY2010 · CA
Personalized vaccine immunotherapy in combination with anti-PD 1 antibody for recurrent or metastatic squamous cell carcinoma of the head and neck
$629,482Dong Moon Shin · Emory University · R01 · FY2025 · CA
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
$629,475Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2019 · CA
Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19
$629,459Michael R Wilson · University Of California, San Francisco · R01 · FY2023 · NS
T-cell intrinsic mechanisms of resistance to PD-1 checkpoint blockade
$629,441Michelle Krogsgaard · New York University School Of Medicine · R01 · FY2022 · CA